rGIFT15: Recombinant Fusion Protein for the Treatment of Autoimmune Diseases
Application
Recombinant fusion protein comprising GM-CSF and interleukin-15 for treating autoimmune diseases.
Key Benefits
rGIFT15 lacks any post-translation modification such as glycosylation.
Market Summary
For those suffering from autoimmune diseases current therapies treat the symptoms, but do not provide a cure and currently available immunosuppressant...
Published: 7/28/2023
Contributor(s): Jacques Galipeau, Andrea Pennati
|